INTRODUCTION
CXCR2 was cloned in 1991 (Holmes et al., 1991; Murphy and Tiffany 1991) and is expressed on myeloid cells in the periphery as well as on oligodendrocyte progenitor cells (OPCs) in the central nervous system (CNS). With its seven differentially regulated ligands, CXCR2 shows multiple additional functions beyond chemoattraction for myeloid cell trafficking (Cacalano et al., 1994) . On OPCs in the developing rodent spinal cord, CXCR2 interacts with CXCL1, arresting migrating OPCs during development, and promoting the OPC proliferative response to PDGFA (Tsai et al., 2002) . CXCR2 also plays a role in wound healing (Devalaraja et al., 2000) , acetaminophen hepatotoxicity (Hu and Colletti 2010) , bone mineralization, intramembranous bone formation (Bischoff et al., 2011) , spontaneous tumorigenesis (Jamieson et al., 2012) , cancer metastasis and chemoresistance (Acharyya et al., 2012) . Recently we and others found that CXCR2 function on neutrophils plays a role in both autoimmune and toxic demyelination (Carlson et al., 2008; Liu et al., 2010a) as well as myelin repair (Liu et al., 2010b) . Importantly, CXCR2 plays orthologous roles in humans and rodents (Mihara et al., 2005) .
CXCR2 deficient mice (Cxcr2 -=-) (Cacalano et al., 1994) are fragile and infertile, which complicates breeding and disease modeling. We generated Cxcr2 fl=fl mice to extend research into cell-type specific and inducible deletion of this pleiotropic receptor. In transgenic mice expressing inducible Cre recombinase under control of the Mx1 promoter (Mx-Cre), our induction protocol efficiently deleted the floxed Cxcr2 gene in hematopoietic cells. Cxcr2-CKO mice 4 weeks after poly(I:C) injections showed deletion of CXCR2 on peripheral neutrophils and deficient neutrophil migration. Our data indicate that Cxcr2 fl=fl mice provide a useful reagent to advance current research into CXCR2 and its chemokine ligands in inflammation, cancer and neurological disease.
RESULTS AND DISCUSSION

Generation of Cxcr2 Conditional Knockout (Cxcr2-CKO) Mice
A Cxcr2 conditional targeting construct was generated by recombineering and electroporated into C57BL/6 ES cells, which were screened by Southern blotting (Fig.  1A) . Twenty-five candidate ES cell lines were verified both through 3' screening (Fig. 1A , data not shown) and sequence analysis through the loxP and FRT sites (data not shown). One correct ES clone (clone 1) from seven candidates was re-confirmed by sequence analysis of the loxP and FRT sites (data not shown).
Chimeric founder mice harboring the Cxcr2 fl=1 allele were intercrossed to generate Cxcr2 fl=fl mice. To create the Cxcr2-CKO mouse line, Cxcr2 fl=fl mice were bred to Mx-Cre mice (Kuhn et al., 1995) and intercrossed to generate 
Expression of CXCR2 in Cxcr2 fl=fl Mice
The Cxcr2 fl allele was detected with F5FRT and R6FRT primers (Fig. 1B-a intensity to Cxcr2 1=1 mice (Fig. 2 ). Spleen and bone marrow from Cxcr2 fl=fl and Cxcr2 1=1 mice showed similar CXCR2 expression patterns as peripheral blood (Supporting Information 2, data not shown). ::Mx-Cre 1 or Cxcr2 fl=fl mice (Fig. 1B) . We analyzed CXCR2 protein product on blood leukocytes weekly after poly(I:C) induction. In Cxcr2-CKO mice, CXCR2 deletion on blood neutrophils was time-dependent. To our surprise, deletion of CXCR2 was first observed at 3 weeks post injection (pi) (Fig.  3b) . At 4 weeks pi, most Cxcr2-CKO mice showed >90% of blood neutrophils were CXCR2-negative (calculated by the ratio of CXCR2 negative cells in total Ly6G1 cells) (Fig. 3b , Supporting Information 2). Cells from the spleen and bone marrow showed equivalent CXCR2 deletion in the neutrophil lineage (Supporting Information 2). Monitoring until 18 weeks pi, showed stable deletion of CXCR2 (Fig. 3b) . Cxcr2-CKO mice showed considerable delay in the appearance of CXCR2-negative circulating neutrophils, as compared with previous studies targeting other cell surface molecules where target-deficient cells are detected within a few days (Tiedt et al., 2008; Ulyanova et al., 2007; Yan, 2008) . Before appearance of CXCR2-deficient leukocytes in the circulation, necessary events include activating the Mx1 promoter with poly(I:C)-induced type I IFN, producing Cre recombinase, and recombining the floxed gene. Thereafter, turn-over of the targeted protein or cells expressing that protein must occur before target-negative cells predominate (Nagy, 2000) . It remains plausible that retention of CXCR2-deficient neutrophil progenitors in bone marrow (K€ ohler et al., 2011) accounts for the failure of CXCR2-negative neutrophils to accumulate in the bloodstream. In particular, neutrophil progenitors remaining CXCR21 will be privileged for bone marrow exit and that population must be exhausted before CXCR2-deficient cells will appear in the periphery. Cxcr2 fl=fl ::Mx-Cre 1 mice were born at expected Mendelian ratios and showed normal weight, behavior, fertility and life span. Cxcr2-CKO mice lost weight compared with littermates after efficient CXCR2 deletion on neutrophils (data not shown), reminiscent of 
CXCR2-Deficient Neutrophils Show Defective Ligand Scavenging
Signaling chemokine receptors such as CXCR2 scavenge their ligands (Cardona et al., 2008) . CXCR2 ligand CXCL1 was undetectable in plasma of Cxcr2 fl=fl or Cxcr2 1=1 mice, while being present at high levels in plasma from positive control Cxcr2 -=-animals showing that the Cxcr2 fl=fl targeted allele scavenged efficiently (Fig. 4 , data not shown). Cxcr2-CKO mice with more than 90% CXCR2 deletion on neutrophils showed dramatically increased plasma CXCL1 in the serum comparable with those in Cxcr2 -=-mice (Fig. 4) . However, Cxcr2-CKO mice with less than 90% CXCR2 deletion on neutrophils showed comparable levels of plasma CXCL1 to control mice (Fig. 4) . These results indicate that near-complete induction of CXCR2 deficiency on peripheral neutrophils is required to abrogate the scavenging of CXCL1.
Dose-Dependent Recombination Induced by poly(I:C) in Periphery But Not CNS of Cxcr2-CKO Mice After four injections at 2.5 mg/kg poly(I:C), we observed 30% deletion of CXCR2 on neutrophils while 15 mg=kg poly(I:C) induced >90% deletion on neutrophils at 4 weeks pi, 6 weeks pi and 8 weeks pi (Fig. 5a) . Concerned with effects of the 15 mg=kg poly(I:C), including inflammatory cytokine (TNF-a, IL-6, or IFNg) production and sickness behavior 1=1 and Cxcr2 -=-mice (top) were used as positive and negative controls respectively. These data represent at least three independent experiments. (Cunningham et al., 1997) which could confound data analysis for neuroinflammatory disease models, we examined the timing of poly(I:C) injections at lower doses of poly(I:C). At 5 mg=kg poly(I:C) with assay 4 wks pi, we observed partial CXCR2 deletion from circulating neutrophils of mice injected at ages >8 weeks. Using the same dose and timing of assay, we observed >90% CXCR2 deletion on neutrophils of most mice injected at 4 weeks of age (Fig. 5b) . Compared with 5 mg=kg, high-doses (15 mg=kg) of poly(I:C) once every other day for four injections did not alter the extent or kinetics for generating CXCR2-negative blood neutrophils in young mice (3-4 week old). However, high-dose poly(I:C) caused more-efficient CXCR2 deletion on neutrophils in older mice (>8 week old). We concluded that, 5 mg=kg was an appropriate dose of poly(I:C) for the CXCR2 deletion in young Cxcr2-CKO mice avoiding the neurotoxic effects caused by high-dose poly(I:C).
To determine whether the deletion of CXCR2 differed in the periphery from the CNS, we performed qPCR to examine Cre expression. Cre recombinase induction in spleen (200-fold) was far greater than that in the brain (six-fold) (Fig. 5c ). To determine if low-level induction of Cre recombinase mediated recombination in CNS parenchyma, we crossed MxCre mice to reporter ROSA26mTmG mice (Muzumdar et al., 2007) , and monitored recombination as conversion from tomato red to GFP labeled cells in the CNS. There were no green neuroepithelial parenchymal CD45 negative cells in the CNS 4 weeks after injection of 5 mg=kg poly(I:C) by flow cytometry (data not shown), which is consistent with a previous finding (Kuhn et al., 1995) . ::Mx-Cre 1 mice before injection (a, top) and 4 week after injection (a, bottom), were stained with Ly6GFITC and CXCR2PE antibodies and were analyzed by flow cytometry. These data represent at least three independent experiments. (b) CXCR2 deletion is time dependent and irreversible. Peripheral blood cells collected from Cxcr2 fl=fl ::Mx-Cre 1 mice before injection, at 2, 3, 4, and 18 weeks after poly(I:C) injection, were stained with Ly6GFITC and CXCR2PE antibodies and were analyzed by flow cytometry. The percentage indicated in the figures is CXCR2 positive neutrophils in the total peripheral blood cells. These data represent at least three independent experiments.
NEUTROPHIL CXCR2 CONDITIONAL DELETION
Decreased Migration of CXCR2-Deficient Neutrophils in Sterile Peritonitis
To assess neutrophil migration toward an inflammatory stimulus in Cxcr2-CKO mice, the sterile irritant thioglycollate (TG) was administered i.p. Total peritoneal cell number was reduced by about 50% in Cxcr2-CKO mice (0.32 6 0.02310 6 =mL) as compared with the Cxcr2 fl=1 : :Mx-Cre 1 group (0.59 6 0.10 3 10 6 =mL, P 5 0.022) due to the virtual absence of recruited neutrophils in Cxcr2-CKO mice (Fig. 6a,b) . Giemsa-stained cytospin preparations from the peritoneal cavity showed more macrophage-like cells in Cxcr2-CKO mice than in Cxcr2 fl=1 ::Mx-Cre 1 mice (Fig. 6c) . In Cxcr2 fl=1 ::Mx-Cre 1 mice, CXCR2 expression was downregulated on infiltrated peritoneal neutrophils (Fig. 6d) suggesting receptor engagement during migration.
Our current data indicate that the floxed Cxcr2 gene was deleted by induction of Cre recombinase in Cxcr2 fl=fl mice, providing opportunities to elucidate the functions of CXCR2 and its many chemokine ligands in murine models of human disorders such as neurodegenerative disease and cancer.
METHODS
Mice
The Cxcr2 targeting construct for generation of a conditional Cxcr2 allele was built by recombineering (Liu FIG. 4 . CXCR2-deficient neutrophils show defective ligand scavenging. ELISA assays for CXCL1 were performed on sera from Cxcr2
1=1
, Cxcr2 -=-, Cxcr2 fl=fl mice (data not shown), Cxcr2 fl=1 ::Mx-Cre 1 mice, CKO1 mice: CXCR2 deletion on neutrophils of Cxcr2-CKO mice is less than 90%, and CKO2 mice: CXCR2 deletion on neutrophils of Cxcr2-CKO mice is more than 90%. There is undetectable CXCL1 in the serum of 
Genotyping
The Cxcr2 fl allele was detected with primers which consist of forward primer F5FRT (AGGGAATAGGGGA-TATTTGG) and reverse primer R6FRT (GCTTGGCTGG ACGTAAACTC). Mice were genotyped by amplification of genomic DNA obtained by tail biopsy as shown by Figure 1b . The Cxcr2 1 allele was detected with primers which consist of forward primer F5FRT (AGGGAA-TAGGGGATATTTGG) and reverse primer R3LoxP2 (CGTCTGTGCCTTCTAAGCCT). This PCR reaction yields a 450bp fragment from the Cxcr2 fl allele and 640bp fragment from the Cxcr2 1 allele. The presence of the deleted allele was detected with LoxPF3 primer (CTACTAGCATGTTTGAGCCC) and FrtR primer (CTTGAATGAGGATGGTTGTT), the amplified fragment measured 400bp (Fig. 1b) . This band was purified with ::Mx-Crea QIAGEN PCR Purification Kit (Invitrogen) according to the kit manual and the purified product was sequenced by the Molecular Core Facility in the Cleveland Clinic. For Mx-Cre detection, we redesigned specific primers. One primer is located on the Mx1 promoter (Hug et al., 1988) and another one is on the Cre gene. The PCR product from this pair of primers detects Cre genes expressed under the Mx1 promoter (forward primer: MxPF1: TCCCAACCTCAGTACCAAGC, and reverse primer: Cre2: ATTCTCCCACCGTCAG-TACG, the DNA product measures 800bp (Supporting Information 1). GAPDH primers were used for positive controls as described before (Liu et al., 2010a) .
Injection of poly(I:C) and Analysis of CXCR2 Deletion
Totally, 4-or 8-week-old mice were treated with different doses of poly(I:C) (P1530, Sigma, St. Louis, MO) (2.5 mg=kg, 5 mg=kg, 15 mg=kg) as indicated once every other day for a total of four injections. The time after poly(I:C) injection was counted from the last day of injection (Day 0) as days post injection (pi.).
Deletion of CXCR2 from freshly isolated peripheral leukocytes was determined by flow cytometry. Blood was drawn before the first poly(I:C) injection (time point 0) and once per week for the indicated time. Red blood cells were lysed with red blood cell lysis buffer as decribed previously (Liu et al., 2010a) . For the analysis of percentage of deleted CXCR2 on neutrophils, the peripheral leukocytes were stained with antibody mixtures of CD45APC (Clone: 30-F11; Biolegend), CXCR2PE (Clone: 242216; R&D) and Ly6GFITC (Clone: 1A8; Biolegend) and analyzed with flow cytometry as described previously (Liu et al., 2010a) . The percentage of CXCR2 deleted neutrophils was determined as the ratio of CXCR2 negative neutrophils to the total Ly6G 1 neutrophil population. The percentage of neutrophils in a total blood sample was determined as the ratio of Ly6G 1 in total CD45 1 cells. Analysis was performed with an LSRII (BD Biosciences) equipped with CellQuest software (BD Biosciences), and 10,000 events per sample, were acquired. Data were analyzed with FlowJo software (Tree Star).
ELISA
At the indicated time-points, blood samples were obtained by submandibular puncture. The level of CXCL1 was detected in the sera by ELISA (Duoset, R&D Systems), as described by the manufacturer.
TG-Induced Peritonitis
To study the migration of neutrophils to the site of inflammation in the periphery, inflammation in the peritoneal cavity was induced by using 4% TG medium (Sigma-Aldrich, USA) in ddH 2 O. Autoclaved TG solution was aged in the dark at 4 C for at least 1 week. Mice were injected i.p. with 4% TG solution (1 mL=20 g mouse). After 2 h, mice were sacrificed, and peritoneal leukocytes and blood samples were collected. The neutrophil content in the peritoneal cavity and the blood was determined by flow cytometry. Total cell counts from the peritoneum were performed by hemocytometer (Hausser Scientific, Horsham, PA) immediately following peritoneal cell collection. Cells were stained with antibodies as indicated in data and analyzed by flow cytometry. Some of the cells from the peritoneum were cytospun for Wright-Giemsa staining according to the manufacturer's protocol.
Statistical Analysis
Data are expressed as mean 6 SD. Multiple comparisons were statistically evaluated by 1-way ANOVA using Prism 4 (GraphPad Software). The Students-t-test was used for the comparisons of cytokine content, the percentage of CXCR2 deletion. A P value <0.05 was considered as significant. *P < 0.05, **P < 0.01.
